10/10/2005
ReGen Therapeutics Plc (the ‘Company’)announces that at the Extraordinary General Meeting of the Company held earlier today, Shareholders passed all of the resolutions including those relating to the Placing and the Committed Share Finance Facility, as announced by the Company on 15 September 2005 and as detailed in the circular sent to shareholders dated 16 September 2005.
As a result, it is expected that 66,600,000 new ordinary shares will be allotted to new and existing shareholders at 1p per share (the ‘Second Placing Shares’) raising the Company £666,000, before expenses. Accordingly, the total amount expected to be raised, pursuant to the Placing is £1,566,000, before expenses. Application has been made for the Second Placing Shares, which will rank pari passu with existing ordinary shares in issue, to be admitted to trading to the AIM market of the London Stock Exchange, and it is expected that admission will become effective at 8.00 a.m. on 13 October 2005.
For further information please contact:
Andrew Marshall
Greycoat Communications
Tel: 020 7960 6007
Presentation EGM (1244KB PPT)